PHILADELPHIA, US: FMC Corporation (FMC) has signed a definitive agreement to sell its Epax Omega-3 business to Pelagia AS, a leading producer of pelagic fish products.
The deal is expected to close by the end of Q3 2017.
"We are pleased to sell our Omega-3 business to Pelagia. We believe Pelagia provides a strong strategic fit for our Epax Omega-3 product line and will complement Pelagia's existing portfolio,” said Eric Norris, president, FMC health and nutrition.
Read More: FMC to sell its Omega-3 business to Pelagia
No comments:
Post a Comment